2+ day, 14+ hour ago   (633+ words) Discussions Around the DeLLphi-305 Trial FDA Expands Accelerated Approval of Sevabertinib for HER2-Mutant Non-small Cell Lung Cancer Vanessa Kerry։ Honored to Have Been Appointed as the Director-General's Special Envoy for Health Resilience Hodgkin Lymphoma in 2026: What the New EHA Guidelines…...

2+ day, 14+ hour ago   (605+ words) VIRO 2026 – Global Voices in Renal Oncology Joe Biden Raises Prostate Cancer Awareness, Urges Men to Discuss Screening With Their Doctors HHS Announces Four Key FDA Leadership Selections Across CDER, CBER, CTP and AI Eric Singhi: 10 WCLC26 Abstracts Beyond the Presidentials to…...

2+ day, 19+ hour ago   (108+ words) Eric Miller Leads International Trial Exploring Total Ablative Therapy for Limited Metastatic Colorectal Cancer oncodaily.com Eric Miller Leads International Trial Exploring Total Ablative Therapy for Limited Metastatic Colorectal Cancer Ohio State University Comprehensive Cancer Center-James Cancer Hospital & Solove Research…...

6+ day, 1+ hour ago   (452+ words) Diana Cristina Dragu shared on LinkedIn: “Thinking that there may be a pill somewhere in the world that could potentially keep me alive, while I haven’t found a way to reach it, is a difficult thought to live with. I…...

1+ week, 10+ min ago   (80+ words) Jason Mouabbi, Assistant Professor at MD Anderson Cancer Center, shared on LinkedIn: FDA accelerated approval: camizestrant + CDK4/6i at ESR1 emergence on 1L AI + CDK4/6i (SERENA-6). mPFS 16.0 vs 9.2 mo, HR 0.44. First approval ever driven by ctDNA, not imaging. Molecular progression is now actionable in the…...

1+ week, 19+ hour ago   (99+ words) “Optum and Revolution Medicines you need to communicate and figure out how to get our pancreatic cancer patients access to Daraxonrasib now that this is FDA approved. Denial to a Medicare rural patient under the guise of ‘We cannot find…...

1+ week, 19+ hour ago   (219+ words) Marco Donia, Professor at CCIT-DK, shared by Marie Weitemeyer, PhD Fellow at Copenhagen University Hospital, on LinkedIn. “A small but real OS advantage in patients with resected stage III melanoma, treated with adjuvant anti-PD1 (note however all the limitations of…...

1+ week, 1+ day ago   (1637+ words) Despite decades of research and progress in treatment, metastatic pancreatic cancer remains exceptionally difficult to control, and once the disease progresses after first-line therapy, the options become even more limited. New treatments in this setting have often brought incremental gains…...

1+ week, 3+ day ago   (277+ words) A US skin cancer testing company has agreed to settle allegations that it billed Medicare for potentially unreliable melanoma tests. DermTech Inc., now known as DTech Liquidating Inc., agreed to a settlement valued at up to $5 million, the US Department…...

1+ week, 3+ day ago   (174+ words) Ben Park, Director at Vanderbilt-Ingram Cancer Center, shared on LinkedIn: “Timely access to expert cancer care can make a meaningful difference for patients and their families. Vanderbilt-Ingram Cancer Center offers an expedited pathway for patients with newly diagnosed liver or…...